PRXL up +1.06% percent Today $PRXL High is at 55.19 and the

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
PRXL up +1.06% percent Today $PRXL High is at 55.19 and the Low 54.10 with current volume of 166,259.

Recent News posted below.

Parexel International Corp PRXL other info.
http://investorshangout.com/Parexel-Internati...RXL-55174/

PRXL Parexel International Corp Recent Headline News

Regulatory Affairs Outsourcing Market - Global Industry Analysis 2014 - 2020
M2 - Tue Nov 11, 9:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/8t6h79/regulatory) has announced the addition of the "Regulatory Affairs Outsourcing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" report to their offering. The global regulatory affairs outsourcing market is segmented by services into regulatory affairs; clinical trial applications and product registrations; regulatory writing and publishing; regulatory consulting and legal representation; and others (post approval maintenance, reimbursement consulting etc.). Regulatory writing and publishing services accounted for the largest share of more than 40% of the overall regulatory affairs outsourcing market in 2013 and is expected to maintain its lead during the forecast period through 2014 to 2020. Factors that have contributed towards the large market size of the regulatory writing and publishing services are increasing need for user/reviewer friendly and complete drug application submissions, and sound knowledge for drug development services. Additionally, a well-written clinical study report (CSR) can help in adding a lot of value in the final production of clinical trial documentation, thereby complying with stringent regulatory requirements of the drug development process. The regulatory consulting and legal representation services segment is also estimated to grow at an approximate CAGR of above 14%. The major driving factors for the rapid growth of this segment are growing demand of drug manufacturing companies for product safety and efficacy evaluations. Furthermore, the need of various pharmaceutical companies to minimize business impacts such as product recalls and loss of sales, and ensure global environmental compliance would also propel the growth of the regulatory consulting and legal representation services segment. Currently, the regulatory affairs outsourcing market is fragmented due to the involvement of several established and emerging contract research organizations. Some of the major players operating in the global regulatory affairs outsourcing market are Charles River Laboratories International, Inc., Covance Group Ltd., Parexel International Corporation, WuXi AppTec, Quintiles Transnational Holdings, Inc., Medpace, Inc., Promedica International, Clinilabs, Inc., Accell Clinical Research, LLC, Criterium, Inc., ICON plc and Pharmaceutical Product Development. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Regulatory Affairs Outsourcing Market Overview Chapter 4 Global Regulatory Affairs Outsourcing Market, by Services Chapter 5 Global Regulatory Affairs Outsourcing Market, by Geography Chapter 6 Recommendations Chapter 7 Company Profiles - Accell Clinical Research, LLC - Charles River Laboratories International, Inc. - Clinilabs, Inc. - Covance, Inc. - Criterium, Inc. - ICON plc - Medpace, Inc. - PAREXEL International Corporation - PRA International, Inc. - Pharmaceutical Product Development, LLC - Promedica International - Quintiles Transnational Corporation - WuXi AppTec For more information visit http://www.researchandmarkets.com/research/8t6h79/regulatory
PRXL: 54.92 (+0.42), CRL: 64.16 (+0.23), ICLR: 53.53 (+0.19), CVD: 100.45 (-0.42)

PAREXEL Expands Clinical Trial Supply And Logistics Services Through Opening Of New European Coordination Hub and Distribution Center
PR Newswire - Tue Nov 11, 5:00AM CST
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the opening of its new European Coordination Hub and Distribution Center in Berlin-Schonefeld, Germany. The facility expands the Company's capacity to provide comprehensive clinical trial supply and logistics services to support clients' local, regional and global trial requirements. These capabilities include synchronized coordination of clinical trial supplies, ancillary supplies and central laboratory services.
PRXL: 54.92 (+0.42)

Post Earnings Update: Parexel International Has Sunk 15.1% Lower in Past Week (PRXL)
Comtex SmarTrend(R) - Mon Nov 10, 12:17PM CST
12 days ago, on October 29th, 2014, Parexel International (NASDAQ RXL) reported its earnings. Analysts, on average, expected earnings of $0.58 per share on sales of $499.4 million. Parexel International actually reported earnings of $0.65 per share on sales of $573.7 million, beating EPS estimates by $0.07 and beating revenue estimates by $74.3 million. Since the company's report, shares of Parexel International have fallen from $63.56 to $53.97, representing a loss of 15.1% in the past 12 days.
PRXL: 54.92 (+0.42)

PAREXEL International to Present at Jefferies Global Healthcare Conference
PR Newswire - Mon Nov 10, 8:30AM CST
PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Jefferies Global Healthcare Conference in London. Ingo Bank, Senior Vice President and Chief Financial Officer, will be making a presentation on PAREXEL and discussing business developments at 1:00pm GMT on Thursday, November 20, 2014.
PRXL: 54.92 (+0.42)

Insider Trading Alert - PRXL, SCOR And HLF Traded By Insiders
at The Street - Fri Nov 07, 11:30AM CST
Stocks with insider trader activity include PRXL, SCOR and HLF
HLF: 37.48 (-0.66), PRXL: 54.92 (+0.42), SCOR: 43.23 (-0.04)

PAREXEL International Beats Q1 Earnings, Misses Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 9:48AM CST
PAREXEL International (PRXL) reported adjusted earnings per share of 65 cents in the first quarter of fiscal 2015, which beat both the Zacks Consensus Estimate of 58 cents and the year-ago earnings of 45 cents.
BGMD: 0.47 (+0.03), PRXL: 54.92 (+0.42), BEAT: 8.20 (unch), ICLR: 53.53 (+0.19)

PAREXEL International To Present At Credit Suisse Healthcare Conference
PR Newswire - Tue Nov 04, 8:50AM CST
PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Credit Suisse Healthcare Conference in Phoenix, AZ. Ingo Bank, Senior Vice President and Chief Financial Officer, will be making a presentation on PAREXEL and discussing business developments at 1:00 p.m. MST on Tuesday, November 11, 2014.
PRXL: 54.92 (+0.42)

Quarterly Financial Results and Product Approval - Research Reports on Pacira, PAREXEL, WellPoint, Illumina and St. Jude Medical
PR Newswire - Tue Nov 04, 8:00AM CST
Today, Analysts Review released its research reports regarding Pacira Pharmaceuticals Inc. (NASDAQ: PCRX), PAREXEL International Corporation (NASDAQ: PRXL), WellPoint Inc. (NYSE: WLP), Illumina, Inc. (NASDAQ: ILMN) and St. Jude Medical, Inc. (NYSE: STJ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7670-100free.
PRXL: 54.92 (+0.42), STJ: 65.54 (-0.16), ILMN: 188.08 (-0.19), PCRX: 87.24 (-0.59), WLP: 126.70 (+1.20)

Nasdaq stocks posting largest percentage decreases
AP - Thu Oct 30, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
BBOX: 23.38 (+0.15), AFOP: 13.70 (unch), AMCC: 6.34 (+0.02), NSIT: 23.29 (+0.11), ARAY: 7.00 (+0.10), HTWR: 79.27 (+0.66), CCUR: 7.00 (-0.05), THRM: 41.32 (+0.55), RPXC: 13.97 (+0.02), BWEN: 6.56 (+0.01), PRXL: 54.92 (+0.42), AZPN: 38.02 (-0.01), BBSI: 23.07 (-1.21), CRUS: 19.55 (-0.14), ARCP: 8.65 (+0.15), PCRX: 87.24 (-0.59), XOOM: 15.02 (+0.36)

Parexel International Falls 16.38% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Thu Oct 30, 3:47PM CDT
Parexel International (NASDAQ RXL) traded in a range yesterday that spanned from a low of $52.86 to a high of $55.77. Yesterday, the shares fell 16.4%, which took the trading range below the 3-day low of $62.48 on volume of 5.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
PRXL: 54.92 (+0.42)

PAREXEL International's (PRXL) CEO Josef H. von Rickenbach on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 2:40PM CDT

PRXL: 54.92 (+0.42)

Stocks Improve In Afternoon Trading; Taser Surges On Earnings
at Investor's Business Daily - Thu Oct 30, 12:25PM CDT
Stocks improved Thursday afternoon as the Nasdaq entered positive territory, but just barely. The Dow Jones industrial average continued to lead, with a 0.9% gain. Visa (V), which reported better-than-expected earnings Wednesday, was the Dow's bigger...
ABC: 87.87 (+0.16), PRXL: 54.92 (+0.42), BIDU: 248.49 (+0.91), V: 249.35 (-0.86), TASR: 19.59 (+0.66)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 11:47AM CDT

ABMD: 33.02 (+0.03), CALX: 11.37 (-0.01), LOJN: 2.72 (+0.03), ALU: 3.17 (unch), CDTI: 2.48 (-0.16), NKA: 4.63 (-0.20), ARAY: 7.00 (+0.10), GLUU: 3.84 (+0.05), PDII: 1.78 (+0.03), OMER: 19.00 (+1.51), ESBF: 18.85 (+0.02), CRNT: 1.11 (-0.03), CBDE: 0.95 (+0.02), PRXL: 54.92 (+0.42), BWEN: 6.56 (+0.01), ALDX: 7.77 (-0.14), BBSI: 23.07 (-1.21), LAKE: 12.75 (-0.23), OPHC: 0.94 (+0.02), WTW: 25.90 (+0.28)

PAREXEL International (PRXL) Stock Lower After Weak Fiscal 2015 First Quarter Revenue Results
at The Street - Thu Oct 30, 10:37AM CDT
Shares of PAREXEL (PRXL) are down after reporting lower 2015 first quarter fiscal year revenue results that missed analysts' estimates.
PRXL: 54.92 (+0.42)

Stocks Turn Mixed As Dow Rises; Gentherm Tumbles As F5 Rises
at Investor's Business Daily - Thu Oct 30, 9:35AM CDT
Stocks opened lower, but quickly turned mixed Thursday with some support from a better-than-expected third-quarter GDP estimate. The Dow Jones industrial average shed early losses to trade up 0.4%. The Nasdaq slumped 0.5%. The S&P 500 split the...
PRXL: 54.92 (+0.42), CHRW: 71.70 (-0.47), FFIV: 126.43 (-0.16), THRM: 41.32 (+0.55)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 8:18AM CDT

KNDI: 15.57 (+0.71), ALU: 3.17 (unch), CDTI: 2.48 (-0.16), VSR: 3.08 (+0.05), NBG: 2.18 (-0.05), ARAY: 7.00 (+0.10), GLUU: 3.84 (+0.05), OCLS: 1.80 (+0.01), CEMI: 4.34 (+0.19), TTWO: 26.11 (+0.01), PRXL: 54.92 (+0.42), RDN: 16.68 (+0.20), BBD: 14.29 (+0.11), NVAX: 5.30 (+0.09), APT: 3.06 (-0.05), BBSI: 23.07 (-1.21), LAKE: 12.75 (-0.23), GOL: 5.12 (+0.31), TASR: 19.59 (+0.66), AUY: 3.90 (+0.24), PCRX: 87.24 (-0.59), ITUB: 14.09 (-0.02)

Stock Futures Lower, Techs Weak; Visa And Grand Canyon Rising
at Investor's Business Daily - Thu Oct 30, 8:10AM CDT
Stock futures veered lower ahead of Thursday's open, with tech stocks and small caps under stress. Dow and S&P 500 futures traded with comparatively mild losses, 28.3 and 11.1 points, respectively, below fair market value. Nasdaq 100 futures slumped...
LOPE: 47.99 (+0.34), PRXL: 54.92 (+0.42), NVO: 44.28 (+0.98), V: 249.35 (-0.86), BIDU: 248.49 (+0.91), APT: 3.06 (-0.05), LAKE: 12.75 (-0.23), JDSU: 13.43 (-0.20)

Downgrade Alert for Parexel International (PRXL)
Comtex SmarTrend(R) - Thu Oct 30, 7:06AM CDT
Parexel International (NASDAQ RXL) was downgraded from Outperform to Neutral at RW Baird today. The stock closed yesterday at $63.56 on volume of 775,000 shares, above average daily volume of 630,000. In the past 52 weeks, shares of Parexel International have traded between a low of $37.53 and a high of $64.72 and closed yesterday at $63.56, which is 69% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.6% while the 200-day MA has risen 0.5%.
PRXL: 54.92 (+0.42)

PAREXEL declines in AH trade on Q1 earnings and lowered guidance
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 6:42PM CDT

PRXL: 54.92 (+0.42)

PAREXEL International Corp. (PRXL) Stock Research Links

PRXL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vail’s Board Fight Puts Strategy Under a Sharp Lens

Updated Category News Views 62

Fresh snow does not make a boardroom dispute disappear. Vail Resorts has put out an investor presentation ahead of its December 14, 2026 annual meeting, asking shareholders to support all nine of management’s director nominees on its white proxy card. That is the formal message. The real message is plainer: NYSE:MTN knows this election has become a test of whether...

Continue Reading
Color Me Mine Tests Florida's Creative Leisure Demand

Updated Category News Views 72

Pottery studios are not exactly the sort of thing that makes markets pound the table, but Florida’s latest Color Me Mine push deserves a closer look. The company signed three franchise agreements in 2026 for Panama City Beach, Doral and Boca Raton, adding planned growth to a state where it already operates 11 studios. For a private franchisor, this is not a quarterly...

Continue Reading
Peptide Labels Cannot Substitute for Clinical Care

Updated Category News Views 151

A Label Is Not a Care Plan Those three little words, research use only, carry far more weight than a flashy product page would have people believe. The HelloNation article featuring wellness expert Andres Giraldo makes a plain but necessary distinction: a research-use-only, or RUO, label does not turn a peptide into prescribed treatment, and it sure does not establish...

Continue Reading
Somerville’s New Immersive Bet Has Room to Grow Locally

Updated Category News Views 74

A passcard, a hidden door, and 12,000 square feet of mischief have landed at Somernova. Edge of Elsewhere, the new flagship attraction from Boston-area creative studio Midnight Mansion, is open in Somerville’s Union Square as of November 18, 2026. It is part interactive art installation, part puzzle game, part physical story world. That sounds delightfully odd, which is...

Continue Reading
Watson Motion Tests Military Pretrial Confinement Rules

Updated Category News Views 170

Military confinement fights are rarely neat, and this one comes with a short clock but plenty of unanswered questions. Defense lawyers for U.S. Air Force Maj. Jason Watson argued on Nov. 17 that he should be released from pretrial confinement while his case proceeds. A military judge is ordinarily expected to issue a ruling within 14 days of the hearing, under the court's...

Continue Reading
AI Gives CPA Firms a New Advisory Staffing Math Today

Updated Category News Views 75

Month-end just got a lot less comfortable for firms living on the clock. Netsurit and Southwestern Talent are pitching the Virtual CFO Platform as a way for CPA firms to turn machine-led analysis into advisory work without first building a costly bench of specialists. That is not a cute workflow tweak. It goes straight at the labor model that has kept plenty of accounting...

Continue Reading
Hanmi Compressor Tests Vietnam Before Wider Expansion

Updated Category News Views 175

Compressed air is the sort of factory necessity nobody brags about until it fails, and that is precisely why Hanmi Compressor’s Vietnam plan deserves a sober look. The Daegu-based specialist is not arriving with a grand export victory lap. It is still building the front door: a website, a promotional video, and a process for finding Vietnamese manufacturers and...

Continue Reading
Hitachi's Quiet Fusion Bet Is Really About Data Control

Updated Category News Views 69

Weeks of engineering work can vanish because one storage system hiccups, which is a rotten way to learn that data infrastructure belongs in the mission-critical column. Esteyco’s new environment, built with Hitachi Vantara and implemented by Quadrics Sistemas, is not a fusion breakthrough. It is the less glamorous machinery that keeps serious fusion research from...

Continue Reading
Emaar's Huspy Deal Brings Financing Into Home Sales

Updated Category News Views 87

Mortgage paperwork is nobody’s idea of luxury, yet it can wreck a property sale faster than a bad floor plan. Emaar Properties has partnered with Dubai-based Huspy to give its customers access to mortgage advice and financing comparisons from more than 20 UAE banks. It is not a flashy tower launch or a headline-grabbing land purchase. Frankly, that is why investors...

Continue Reading
RayNeo's Black Friday Push Tests Smart Glasses Demand

Updated Category News Views 160

A million shipped pairs is a real milestone, but holiday markdowns are where the rubber meets the road for RayNeo. The company is taking its XR gaming glasses and iO AI smart glasses into Europe’s Black Friday scrum with discounts running through late November, betting that portability, giant virtual screens and a little AI convenience can pry open consumers’ wallets....

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Growth of SOC-as-a-Service to $14.66 Billion

Updated Category News Views 198

Understanding SOC-as-a-Service Market Growth The global SOC-as-a-Service market is projected to witness substantial growth, anticipated to reach a value of USD 14.66 billion by 2030. This growth surge represents a remarkable increase from USD 7.37 billion and reflects a compound annual growth rate (CAGR) of 12.2% during the period from 2024 to 2030. The surge in demand...

Continue Reading
Revolutionary Anti-Aging Hair Solution Launches for Men

Updated Category News Views 308

Just For Men® Launches Gray Reverse™ Hair Serum In an exciting development for men's grooming, Just For Men® has unveiled its latest innovation, the Gray Reverse™ Hair Serum. This groundbreaking product is designed to help men fight against the signs of aging, specifically graying hair, and play a key role in maintaining their natural appearance. Understanding the...

Continue Reading
Legal Guidance for Lantheus Holdings Investors Amid Class Action

Updated Category News Views 242

Introduction to Lantheus Holdings Lantheus Holdings, Inc. (NASDAQ: LNTH) stands as a significant player in the medical technology sector, specializing in diagnostic imaging and therapeutic agents. The company focuses on enhancing diagnosis, treatment, and monitoring of various health conditions. As it gears up for a challenging period marked by considerable scrutiny,...

Continue Reading
OpenAI Explores Development of Innovative Web Browser

Updated Category News Views 167

OpenAI Explores Development of Innovative Web Browser OpenAI, the company behind the popular AI chatbot ChatGPT, is taking strategic steps that could reshape the landscape of web browsing. Recently, it has been reported that OpenAI is contemplating the creation of a new web browser that could work harmoniously with its advanced chatbot technologies. This potential...

Continue Reading
Mercedes-Benz Faces Challenges with New FY24 Financial Guidance

Updated Category News Views 355

Mercedes-Benz Updates Fiscal Year 2024 Projections Recently, the Mercedes-Benz Group adjusted its financial outlook for the fiscal year 2024. Despite this reevaluation, Morgan Stanley has chosen to keep its Overweight rating on Mercedes-Benz (OTC: MBGAF) along with a solid price target of EUR 82.00. This decision comes even as the company revised its financial...

Continue Reading